These results indicated that the expression of MT2A, MT1E and MT1X in CD8+ T cells of PD-1 mMAB resistant ESCC patients is decreased, which may be related to the poor sensitivity of PD-1 mMAB. This evidence concerns the gene MT2A and esophageal squamous cell carcinoma.